Harry Stratford31 Mar 2016 09:42
Harry Stratford has over 40 years' experience in the pharmaceutical industry and has built two successful publicly listed pharmaceutical companies. Harry founded Shire Plc in 1986 and was CEO for almost a decade. The Company has grown from humble beginnings to be one of Europe's largest specialty pharmaceutical companies with a market cap of around $40 billion and its stock is a constituent of the FTSE100 index. Harry then went on to be founder, CEO and Executive Chairman of Prostrakan Plc, another International specialty pharmaceutical company, which was subsequently acquired by Kyowa Hakko Kirin of Japan in 2011.
Harry holds a BSc. in Chemistry from the University of London and was awarded an OBE in the 2007 New Year's Honours list for his contribution to the Scottish Life Sciences Industry.